Sensitization for anticancer drug-induced apoptosis by betulinic acid

Neoplasia

Volumn 7, Issue 2, 2005, Pages 162-170

  Fulda, Simone ^a   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Betulinic acid; Cancer; Mitochondria; Resistance

Indexed keywords

ANTINEOPLASTIC AGENT; BETULIC ACID; CASPASE; CISPLATIN; CYTOCHROME C; CYTOTOXIC AGENT; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MUTANT; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIZATION; DRUG SPECIFICITY; ENZYME ACTIVATION; ENZYME RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR CELL LINE;

EID: 14644435122     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04442     Document Type: Article

References (23)

1. Peto J (2001). Cancer epidemiology in the last century and the next decade. Nature 411, 390-395.
2. Herr I and Debatin KM (2001). Cellular stress response and apoptosis in cancer therapy. Blood 98, 2603-2614.
3. Lowe SW and Lin AW (2000). Apoptosis in cancer. Carcinogenesis 21, 485-495.
4. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407, 770-776.
5. Debatin KM, Poncet D, and Kroemer G (2002). Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21, 8786-8803.
6. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, and Vandenabeele P (2002). The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9, 1031-1042.
7. Johnstone RW, Ruefli AA, and Lowe SW (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164.
8. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown DM, et al. (1995). Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1, 1046-1051.
9. Fulda S, Jeremias I, Pietsch T, and Debatin KM (1999). Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr 211, 319-322.
10. Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C, and Formelli F (2002). Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175, 17-25.
11. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer G, Peter ME, and Debatin KM (1997). Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57, 4956-4964.
12. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, and Debatin KM (1998). Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273, 33942-33948.
13. Fulda S, Sieverts H, Friesen C, Herr I, and Debatin KM (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57, 3823-3829.
14. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271-279.
15. Fulda S and Debatin KM (2004). Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64, 337-346.
16. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N, and Kroemer G (2002). Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 265, 39-47.
17. + subpopulation of leukemia cells. Leukemia 17, 2130-2139.
18. Kim B and Feldman EL (2002). Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and akt. J Biol Chem 277, 27393-27400.
19. Lassus P, Opitz-Araya X, and Lazebnik Y (2002). Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352-1354.
20. Fulda S, Jeremias I, Steiner HH, Pietsch T, and Debatin KV (1999). Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 82, 435-441.
21. Tan Y, Yu R, and Pezzuto JM (2003). Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin Cancer Res 9, 2866-2875.
22. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B, and Kodym R (2000). Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 114, 935-940.
23. Udeani GO, Zhao GM, Geun Shin Y, Cooke BP, Graham J, Beecher CW, Kinghorn CW, and Pezzuto JM (1999). Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm Drug Dispos 20, 379-383.